S-allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling

Publication date: Available online 13 November 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Pingping Luo, Ming Zheng, Rui Zhang, Hong Zhang, Yingxia Liu, Wei Li, Xiaoming Sun, Qian Yu, George L. Tipoe, Jia Xiao
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research